2. Academic Validation
  3. Design and Development of Microformulations for Rapid Release of Small Molecules and Oligonucleotides

Design and Development of Microformulations for Rapid Release of Small Molecules and Oligonucleotides

  • Eur J Pharm Sci. 2023 May 21;106472. doi: 10.1016/j.ejps.2023.106472.
T Brown 1,  M Stanton 1,  F Cros 2,  S Cho 2,  A Kiselyov 3
Affiliations

Affiliations

  • 1 Mosaic Biosciences, 2830 Wilderness Pl, Boulder, CO, 80301, USA.
  • 2 Bionaut Labs, LLC, 3760 Overland Avenue, Los Angeles, CA, 90034, USA.
  • 3 Bionaut Labs, LLC, 3760 Overland Avenue, Los Angeles, CA, 90034, USA. Electronic address: [email protected].
PMID: 37220816 DOI: 10.1016/j.ejps.2023.106472
Abstract

A systemic delivery of therapeutics frequently results in sub-optimal exposure of the targeted locus and undesired side effects. To address these challenges, a platform for local delivery of diverse therapeutics by remotely controlled magnetic micro-robots was introduced. The approach involves micro-formulation of active molecules using hydrogels that exhibit wide range of loading capabilities and predictable release kinetics. This work introduces two specific hydrogels based on thiol-maleimide and PEG-PLA-diacrylate chemistries that afford high, reliable and reproducible loading and release of several model molecules including doxorubicin, 25-mer poly-dT oligonucleotide and a 5.4 kBp GFP DNA plasmid. The described formulations are suitable for micro-dosing using both conventional or remote delivery devices.

Keywords

DNA plasmid; Hydrogel; PEG-PLA-Diacrylate; doxorubicin; micro-formulation; oligonucleotide; thiol-maleimide.

Figures
Products